If you are a physician or caregiver and believe you have a patient who may qualify - click here for more information

CLINICAL STUDY FOR CRITICAL LIMB ISCHEMIA (CLI)

Have you been diagnosed with Peripheral Arterial Disease (PAD) and/or Critical Limb Ischemia (CLI)?

Leg Amputation alternatives

If you suffer from Critical Limb Ischemia and have been told by a physician that you are no longer a candidate for surgical or other interventional treatment, you may be eligible for a clinical study of an investigational treatment for patients with advanced CLI.

The study seeks to determine if treatment with adult stem cells, taken from the patient’s own bone marrow, can improve healing and prevent amputation.

CLICK HERE TO SEE IF YOU QUALIFY

 

Clinical Trial Study

Lifecells, LLC is sponsoring a study to assess the efficacy and safety of ASCT01 (autologous stem cell transplantation) in patients with Critical Limb Ischemia (CLI).

This study is being conducted at:

Kansas City Vascular Foundation (KCV), 
North Kansas City, Missouri, United States, 64116.
by Dr. Karl Stark, MD FACS

The title of the study is:

An open-label single arm phase 2 study to assess the efficacy and safety of ASCT01 in Patients with Critical Limb Ischemia

Read More

PHYSICIANS/PROVIDERS

Have a patient that may benefit from participation in this trial?

The Clinical Trial is a Phase 2, open-label proof of concept study to assess the efficacy and safety of ASCT01 in Patients with Critical Limb Ischemia (CLI).

The purpose of the study is to assess the efficacy and safety of ASCT01 (autologous stem cell transplantation) prepared from the patient's own bone marrow and delivered by catheter for intra-arterial administration and intra-muscular injections in patients with CLI.

READ MORE
 
Contact Us       |        See if You Qualify        |        Sign Up for Participation        |        Study Information